Guselkumab, Risankizumab Boast Longest Drug Survival Among IL-17, IL-23 Inhibitors
A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.
A recent meta-analysis of more than 60 studies suggests guselkumab and risankizumab had the longest drug survival of IL-17 and IL-23 inhibitors for psoriasis.
This updated summary covers the diagnosis, management, and referral of people with earwax impaction
Who better to drive clean-energy investment than some of the world’s biggest and most profitable companies?
Katie Titman says she was “gobsmacked” to be up and about within a week of the procedure.
DARPA has finally unveiled more of its mysterious Manta Ray robotic sub, with impressive new images of the prototype Uncrewed Underwater Vehicle (UUV) undergoing its…
About 55 people will sleep in the grounds of Peel Castle in support of charity Breast Cancer Now.
It uses sculptures to explain the most common symptoms of rare cancers called MPNs.
Walkers in a Devon village say neglect has made the footpath almost “impossible” to use safely.
Trusted technology for atrial fibrillation
In four large US cohorts including more than 13,000 adults, a unique metabolomic signature of a healthy lifestyle was identified and replicated. The signature is…
Background: Congenital enterocolic fistula, an abnormal connection between the small intestine and the colon, is a rare condition with the potential for significant complications affecting…